TY  - JOUR
AU  - Morel, Chantal M
AU  - Alm, Richard A
AU  - Årdal, Christine
AU  - Bandera, Alessandra
AU  - Bruno, Giacomo M
AU  - Carrara, Elena
AU  - Colombo, Giorgio L
AU  - de-Kraker, Marlieke E A
AU  - Essack, Sabiha
AU  - Frost, Isabel
AU  - Gonzalez-Zorn, Bruno
AU  - Goossens, Herman
AU  - Guardabassi, Luca
AU  - Harbarth, Stephan
AU  - Jørgensen, Peter S
AU  - Kanj, Souha S
AU  - Kostyanev, Tomislav
AU  - Laxminarayan, Ramanan
AU  - Leonard, Finola
AU  - Hara, Gabriel Levy
AU  - Mendelson, Marc
AU  - Mikulska, Malgorzata
AU  - Mutters, Nico T
AU  - Outterson, Kevin
AU  - Baňo, Jesus Rodriguez
AU  - Tacconelli, Evelina
AU  - Scudeller, Luigia
PY  - 2020
DO  - 10.1186/s13756-020-00822-6
UR  - http://hdl.handle.net/10668/16673
T2  - Antimicrobial resistance and infection control
AB  - The costs attributable to antimicrobial resistance (AMR) remain theoretical and largely unspecified. Current figures fail to capture the full health and economic burden caused by AMR across human, animal, and environmental health; historically many...
LA  - en
PB  - BioMed Central Ltd.
KW  - Antimicrobial resistance
KW  - Cost
KW  - One health
KW  - Animals
KW  - Cost of Illness
KW  - Cost-Benefit Analysis
KW  - Drug Resistance, Microbial
KW  - Health Care Costs
KW  - Humans
KW  - Infections
KW  - One Health
TI  - A one health framework to estimate the cost of antimicrobial resistance.
TY  - research article
VL  - 9
ER  -